Sign In
Buy INVA
$21.70
+0.350 (+1.64%)
At Close: Jun 03, 2026
Tracking Ken Fisher's Fisher Asset Management Portfolio - Q2 2020 Update
07:49am, Tuesday, 11'th Aug 2020
Fisher’s 13F portfolio value increased from $80.64B to $102.5B in Q2 2020. They increased PayPal, Walt Disney, NextEra Energy, UnitedHealth, 3M Company, Intuitive Surgical, Abbott Labs, Starbucks, a
IPO Update: CureVac Readies Plans For U.S. IPO (Pending:CVAC)
04:44pm, Monday, 10'th Aug 2020
CureVac has filed to raise $200 million in a U.S. IPO and another $118 million in a concurrent private placement.
The Never Coming Stock Market Crash - Smart Money Is Still Waiting, Here's What I Do
01:10pm, Monday, 10'th Aug 2020
My article The Coming Stock Market Crash - Smart Money Is Already Ringing The Death Bell was by far my most successful piece on Seeking Alpha.
Dividend Income Summary: Lanny's July 2020 Summary
08:56am, Monday, 10'th Aug 2020
Despite the pandemic from COVID-19, dividend income continues to grow, due to additional investment and reinvestment.
MorphoSys AG (MOR) CEO Jean-Paul Kress on Q2 2020 Results - Earnings Call Transcript
08:46am, Sunday, 09'th Aug 2020
MorphoSys AG (NASDAQ:MOR) Q2 2020 Earnings Conference Call August 06, 2020, 08:00 AM ET Company Participants Anja Pomrehn - Head of IR Jean-Paul Kress - CEO Jens Holstein - CFO Malte Peters - Chief Re
Orchard Therapeutics plc (ORTX) CEO Bobby Gaspar on Q2 2020 Results - Earnings Call Transcript
07:32pm, Saturday, 08'th Aug 2020
Orchard Therapeutics plc (NASDAQ:ORTX) Q2 2020 Results Conference Call August 06, 2020 08:00 AM ET Company Participants Renee Leck - Investor Relations Bobby Gaspar - Chief Executive Officer Frank Tho
Merck KGaA (MKGAF) CEO Stefan Oschmann on Q2 2020 Results - Earnings Call Transcript
07:29pm, Saturday, 08'th Aug 2020
Merck KGaA (OTCPK:MKGAF) Q2 2020 Results Conference Call August 6, 2020 8:00 AM ET Company Participants Constantin Fest - IR Marcus Kuhnert - CFO Stefan Oschmann - CEO Conference Call Participants Mat
Theravance Biopharma's (TBPH) CEO Rick Winningham on Q2 2020 Results - Earnings Call Transcript
03:11pm, Saturday, 08'th Aug 2020
Theravance Biopharma, Inc. (NASDAQ:TBPH) Q2 2020 Earnings Conference Call August 6, 2020 5:00 PM ET Company Participants Gail Cohen – Vice President, Corporate Communications and Investor Relations
Can you spot patients' acidic damage? – Dentistry Online
08:20am, Friday, 07'th Aug 2020
Pronamel from GSK is launching its dedicated resource page highlighting the important role acid plays in your patients' diet.
Tweedy, Browne Fund Q2 2020 Commentary
05:25am, Friday, 07'th Aug 2020
Tweedy, Browne Company LLC provides investment advisory services. The Company offers portfolio management, financial planning, and consulting services for individuals, institutions, partnerships, pens
The Daily Biotech Pulse: Novavax Vaccine Deals, Trevena Awaits FDA Decision, 2 IPOs
12:00am, Friday, 07'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 6)
ADiTx Therapeutics Inc (NASDAQ: ADTX) (announced introduction of AditxtScore for COVID-19 to be used in detecting...
Xconomy: GlaxoSmithKline Multiple Myeloma Drug Earns FDA’s First Anti-BCMA Nod
11:49pm, Thursday, 06'th Aug 2020
Patients with advanced multiple myeloma have a new treatment option with the FDA’s approval of a GlaxoSmithKline drug that targets B-cell maturation
CureVac Starts U.S. IPO Effort (Pending:CVAC)
08:29pm, Thursday, 06'th Aug 2020
CureVac B.V. has filed to raise $100 million in a U.S.
Emergent BioSolutions: The Indirect COVID-19 Vaccine Play Looks Undervalued (NYSE:EBS)
05:37pm, Thursday, 06'th Aug 2020
The manufacturing deals for candidates set the stage for Emergent to ride the momentum of COVID-19 vaccine development.
When this FTSE 100 share drops below £16, I’d buy it every single time…
03:32pm, Thursday, 06'th Aug 2020
When this FTSE 100 share drops below £16, its dividend yield rises above 5%. Today, it's slid below £15.50, making me a buyer once again.
